By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech To Present Preclinical Data On Its Viaskin Technology For RSV Vaccination At The 2015 RSV Vaccines For The World Meeting 11/18/2015 10:08:12 AM
DBV Tech Announces Enrollment Of First Patient In Phase IIA Study In Pediatric Eosinophilic Esophagitis 11/13/2015 9:51:37 AM
DBV Tech Reports Interim Financial Results For The Third Quarter Of 2015 11/3/2015 9:16:07 AM
DBV Tech Announces The Appointment Of Michael J. Goller To Its Board Of Directors 10/23/2015 10:12:29 AM
DBV Tech Announces First Patient Enrolled In Phase II Study Of Viaskin Milk 10/14/2015 10:08:26 AM
DBV Tech Release: Follow-Up Study Of Viaskin Peanut Shows Significant Increase In Peanut Consumption And Treatment Benefit In Peanut Allergic Children 10/5/2015 9:43:22 AM
DBV Tech Reports Interim Financial Results For The First Half Of 2015 7/27/2015 1:56:06 PM
DBV Tech: Announces Closing of $281.5 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares 7/21/2015 1:58:28 PM
DBV Tech Announces European Medicines Agency Paediatric Committee (PDCO) Positive Opinion On The Paediatric Investigation Plan For Viaskin Peanut For The Treatment Of Peanut Allergic Children 6/4/2015 9:28:38 AM
DBV Tech Nabs FDA Breakthrough Status for Peanut Allergy Patch 4/10/2015 6:10:06 AM